tiprankstipranks
Advertisement
Advertisement
Scinai Immunotherapeutics Files Pro Forma Financials After February Acquisition of Recipharm Israel
PremiumCompany AnnouncementsScinai Immunotherapeutics Files Pro Forma Financials After February Acquisition of Recipharm Israel
1M ago
Scinai Immunotherapeutics Raises $2.61 Million in ADS and Warrant Financing to Expand CDMO and Immunotherapy Programs
Premium
Company Announcements
Scinai Immunotherapeutics Raises $2.61 Million in ADS and Warrant Financing to Expand CDMO and Immunotherapy Programs
2M ago
Morning News Wrap-Up, 4/24/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up, 4/24/26: Today’s Biggest Stock Market Stories!
2M ago
Scinai Immunotherapeutics targets $5M in CDMO revenue in 2026
PremiumThe FlyScinai Immunotherapeutics targets $5M in CDMO revenue in 2026
3M ago
Scinai Immunotherapeutics Revises €12M FENG Bid and Extends PinCell Option Timeline
Premium
Company Announcements
Scinai Immunotherapeutics Revises €12M FENG Bid and Extends PinCell Option Timeline
3M ago
Scinai Immunotherapeutics Faces Nasdaq Minimum Bid Price Deficiency, Given Until September to Regain Compliance
Premium
Company Announcements
Scinai Immunotherapeutics Faces Nasdaq Minimum Bid Price Deficiency, Given Until September to Regain Compliance
3M ago
Scinai Immunotherapeutics Shareholders Approve Share Increase, Equity Grants and Auditor at December 22 Meeting
PremiumCompany AnnouncementsScinai Immunotherapeutics Shareholders Approve Share Increase, Equity Grants and Auditor at December 22 Meeting
6M ago
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
Premium
Company Announcements
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
7M ago
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
Premium
Company Announcements
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100